Work

NALIRIFOX plus targeted therapy as first-line treatment for metastatic colorectal cancer: A phase I study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3564

Authors: Xiaojing Xu, Hongli Liu, Yanhong Gu, Peng Zhao, Zhigang Peng, Yarong Guo, Hong Qiu, Luoyan Ai, Qing Liu, Shan Yu, Wei Li, Yuehong Cui, Zhiming Wang, Yiyi Yu, Bei Xu, Yan Wang, Xiaojun Xiang, Weidong Pan, Tianshu Liu

Institutions: Fudan University, Zhongshan Hospital, Wuhan Union Hospital, Huazhong University of Science and Technology, Jiangsu Province Hospital, First Affiliated Hospital Zhejiang University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Hospital, Shanghai Medical College of Fudan University, First Affiliated Hospital of Nanchang University, Sixth Affiliated Hospital of Sun Yat-sen University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162505536

Cites:

Cited by:

Related to: